HKU Scholars Hub: Browsing DSpace

Browsing by Author Liao, YJ

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 3 to 16 of 16 < previous

	Title	Author(s)	Issue Date	Views
	Cell cycle-related kinase supports ovarian carcinoma cell proliferation via regulation of cyclin D1 and is a predictor of outcome in patients with ovarian carcinoma Journal:International Journal of Cancer	Wu, GQ Xie, D Yang, GF Liao, YJ Mai, SJ Deng, HX Sze, J Guan, XY Zeng, YX Lin, MC Kung, HF	2009	188
	CHD1L protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival Journal:BMC Cancer	He, WP Zhou, J Cai, MY Xiao, XS Liao, YJ Kung, HF Guan, X Xie, D Yang, GF	2012	54
	CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma. Journal:Carcinogenesis	Li, CP Cai, MY Jiang, LJ Mai, SJ Chen, JW Wang, FW Liao, YJ Chen, WH Jin, XH Pei, XQ Guan, X Zeng, MS Xie, D	2016
	Clusterin as a predictor for chemoradiotherapy sensitivity and patient survival in esophageal squamous cell carcinoma Journal:Cancer Science	He, LR Liu, MZ Li, BK Rao, HL Liao, YJ Zhang, LJ Guan, XY Zeng, YX Xie, D	2009	192
	Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis Journal:Journal of Gastroenterology and Hepatology	Wang, Y Liu, YH Mai, SJ He, LJ Liao, YJ Deng, HX Guan, XY Zeng, YX Kung, HF Xie, D	2010	160
	EZH2 protein: A promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies Journal:Gut	Cai, MY Tong, ZT Zheng, F Liao, YJ Wang, Y Rao, HL Chen, YC Wu, QL Liu, YH Guan, XY Lin, MC Zeng, YX Kung, HF Xie, D	2011	192
	EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin Journal:Oncogene	Tong, ZT Cai, MY Wang, XG Kong, LL Mai, SJ Liu, YH Zhang, HB Liao, YJ Zheng, F Zhu, W Liu, TH Bian, XW Guan, XY Lin, MC Zeng, MS Zeng, YX Kung, HF Xie, D	2012
	EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-β 1 and is a predictor of outcome in ovarian carcinoma patients Journal:Carcinogenesis	Rao, ZY Cai, MY Yang, GF He, LR Mai, SJ Hua, WF Liao, YJ Deng, HX Chen, YC Guan, XY Zeng, YX Kung, HF Xie, D	2010
	High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy Journal:International Journal of Cancer	He, LR Liu, MZ Li, BK Jia, WH Zhang, Y Liao, YJ Chen, YC Zhang, LJ Guan, XY Zeng, YX Kung, HF Xie, D	2010	149
	Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder Journal:Cancer Science	Luo, JH Hua, WF Rao, HL Liao, YJ Kung, HF Zeng, YX Guan, XY Chen, W Xie, D	2009
	Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition Journal:Gut	Zhu, W Cai, MY Tong, ZT Dong, SS Mai, SJ Liao, YJ Bian, XW Lin, MC Kung, HF Zeng, YX Guan, XY Xie, D	2012	156
	Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma Journal:BMC Cancer	He, LR Liu, MZ Li, BK Rao, HL Liao, YJ Guan, XY Zeng, YX Xie, D	2009	138
	The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2 Journal:Gut	Zheng, F Liao, YJ Cai, MY Liu, YH Liu, TH Chen, SP Bian, XW Guan, XY Lin, MC Zeng, YX Kung, HF Xie, D	2012	237
	Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets Journal:PLoS Genetics	Zheng, F Liao, YJ Cai, MY Liu, TH Chen, SP Wu, PH Wu, L Bian, XW Guan, X Zeng, YX Yuan, YF Kung, HF Xie, D	2015

Showing results 3 to 16 of 16 < previous